CliffBio
small molecule

CETAMIDE

SULFACETAMIDE SODIUM

Loss of exclusivity—loss of exclusivity
CompanyAlcon →See this company's full patent-cliff portfolio

Drug detail

Brand nameCETAMIDE
Active ingredientSULFACETAMIDE SODIUM
Strength10%
Dosage formOINTMENT
RouteOPHTHALMIC
ModalitySmall molecule
Marketing statusDISCN

More from Alcon

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

CETAMIDE patent cliff — loss of exclusivity — | CliffBio